articleThe LancetJul 1, 2022GREEN OA

Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial

BKByeong‐Keuk KimSHSung‐Jin HongYLYong‐Joon LeeSJSoon Jun HongKHKyeong Ho Yun

Yonsei University · Severance Hospital · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

299
total citations
FWCI
58.46
Percentile
100%
References
28
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Medicine
  • Ezetimibe
  • Statin
  • Rosuvastatin
  • Internal medicine
  • Clinical endpoint
  • Combination therapy
  • Adverse effect
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.